Citations

Showing 10 of 108094 citations.

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
Sidiqi, M Hasib , Aljama, Mohammed A. , Muchtar, Eli , Warsame, Rahma , Lacy, Martha Q. , Dingli, David , Kumar, Shaji , Kapoor, Prashant , Kourelis, Taxiarchis , Buadi, Francis K. , Kourelis, Taxiarchis V, Gertz, Morie A , Muchtar, E , Sidiqi, M Hasib , Dingli, David , Dispenzieri, Angela , Leung, Nelson , Gonsalves, Wilson I. , Hogan, William J. , Gertz, Morie A.

Mayo Clinic

Blood Advances | April 3, 2018 | Volume: 2 | Issue: 7 | Pages: 769-776

10.1182/bloodadvances.2018016782 | PMID 29615413 Get It

Key Points λ Light chain AL amyloidosis is associated with a shorter PFS and OS compared with κ. Light chain type predicts likelihood of organ involvement in AL amyloidosis.
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk
Orozco, Carlos A. , Martínez‐Bosch, Neus , Guerrero, Pedro Enrique , Vinaixa, Judith , Dalotto‐Moreno, Tomás , Iglesias, Mar , Moreno, Mireia , Djurec, Magdolna, Poirier, Françoise, Fernández-Zapico, Martín E. , Hwang, Rosa F. , Guerra, Carmen , Navarro, Pilar , Navarro, Pilar , Gabius, Hans‐Joachim , Rabinovich, Gabriel A

Mayo Clinic

Proceedings of the National Academy of Sciences | April 3, 2018 | Volume: 115 | Issue: 16 | Pages: No page available

10.1073/pnas.1722434115 | PMID 29615514 Get It

Significance Pancreatic ductal adenocarcinoma (PDA) is the third leading of cause of cancer death in the United States and is predicted to be the second one by 2030. The tumor microenvironment is a major source of soluble mediators that influence tumor progression and hinder the success of therapeutic strategies. Using a genetically engineered mouse model and human cell-based systems, we identify galectin-1 (Gal1) as a critical soluble factor capable of regulating tumor–stroma crosstalk promoting proliferation, angiogenesis, and modulation of inflammatory responses, resulting in enhanced tumor development and metastasis. Our data provide an integrated view of the role of Gal1 in the PDA microenvironment and reinforce the high therapeutic value of Gal1 inhibition in PDA treatment.
ZIP4 Promotes Pancreatic Cancer Progression by Repressing ZO-1 and Claudin-1 through a ZEB1-Dependent Transcriptional Mechanism
Yang, Jingxuan , Zhang, Yuqing , Zhou, Zhijun , Cui, Xiaobo , Zhang, Liyang , Fung, Kar‐Ming , Zheng, Wei , Allard, Felicia D. , Yee, Eric U. , Ding, Kai , Wu, Huanwen , Liang, Zhiyong , Fernández-Zapico, Martín E. , Bronze, Michael S. , Morris, Katherine T. , Postier, Russell G., Yang, Jing , Li, Min , Yang, Jingxuan , Allard, Felicia D , Yee, Eric U , Liu, Mingyang , Zheng, Lei , Li, Yiping , Houchen, Courtney W.

Mayo Clinic

Clinical Cancer Research | April 3, 2018 | Volume: 24 | Issue: 13 | Pages: 3186-3196

10.1158/1078-0432.ccr-18-0263 | PMID 29615456 Get It

Abstract Purpose: ZIP4 is overexpressed in human pancreatic cancer and promotes tumor growth. However, little is known about the role of ZIP4 in advanced stages of this dismal neoplasm. Our goal is to study the underlying mechanism and define a novel signaling pathway controlled by ZIP4-modulating pancreatic tumor metastasis. Experimental Design: The expression of ZIP4, ZO-1, claudin-1, and ZEB1 in human pancreatic cancer tissues, genetically engineered mouse model, xenograft tumor model, and pancreatic cancer cell lines were examined, and the correlations between ZIP4 and those markers were also analyzed. Functional analysis of ZO-1, claudin-1, and ZEB1 was investigated in pancreatic cancer cell lines and orthotopic xenografts. Results: Genetic inactivation of ZIP4 inhibited migration and invasion in pancreatic cancer and increased the expression of ZO-1 and claudin-1. Conversely, overexpression of ZIP4 promoted migration and invasion and increased the expression of ZEB1 and downregulation of the aforementioned epithelial genes. ZIP4 downregulation of ZO-1 and claudin-1 requires the transcriptional repressor ZEB1. Further analysis demonstrated that ZIP4-mediated repression of ZO-1 and claudin-1 leads to upregulation of their targets FAK and Paxillin. Silencing of ZIP4 caused reduced phosphorylation of FAK and Paxillin, which was rescued by simultaneous blocking of ZO-1 or claudin-1. Clinically, we demonstrated that ZIP4 positively correlates with the levels of ZEB1 and inversely associates with the expression of ZO-1 and claudin-1. Conclusions: These findings suggest a novel pathway activated by ZIP4-controlling pancreatic cancer invasiveness and metastasis, which could serve as a new therapeutic target for this devastating disease. Clin Cancer Res; 24(13); 3186–96. ©2018 AACR.
Why Don’t Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer Survivors
Little, Melissa A. , Klesges, Robert C. , Bursac, Zoran , Ebbert, Jon O. , Halbert, Jennifer P. , Dunkle, Andrew N., Colvin, Lauren, Goedecke, Patricia J. , Weksler, Benny

Mayo Clinic

Journal of Cancer Prevention | April 3, 2018 | Volume: 23 | Issue: 1 | Pages: 44-50

10.15430/jcp.2018.23.1.44 | PMID 29629348 Get It

Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Link, Brian K. , Day, Bann‐Mo, Zhou, Xiaolei , Dawson, Keith, Cerhan, James R. , Flowers, Christopher R. , Friedberg, Jonathan W. , Cerhan, James R , Link, Brian K , Zelenetz, Andrew D.

Mayo Clinic

British Journal of Haematology | April 3, 2018 | Volume: 184 | Issue: 4 | Pages: 660-663

10.1111/bjh.15149 | PMID 29611177 Get It

Physician Age and Performance on the American Board of Emergency Medicine ConCert Examination
Wahl, Robert P., House, Hans , Goyal, Deepi G. , Keim, Samuel M. , Joldersma, Kevin B., Johnston, Mary M., Harvey, Anne L., Marco, Catherine A. , John, Oommen

Mayo Clinic

Academic Emergency Medicine | April 2, 2018 | Volume: 25 | Issue: 8 | Pages: 891-900

10.1111/acem.13420 | PMID 29608798 Get It

AbstractObjectiveThis study was undertaken to expand on results from a 2014 study on the association between physician age and performance on the American Board of Emergency Medicine (ABEM) ConCert examination.MethodsThis was a retrospective, longitudinal growth study comparing performance on the ConCert examination and physicians’ ages at the time of examination. All examination attempts from 1990 to 2016 made by residency‐trained physicians were eligible for inclusion. Multilevel growth models were constructed to examine the relationship between age at time of examination and performance, controlling for physician characteristics.ResultsThe study group included 15,533 examination attempts by 12,786 physicians. The mean (±SD) age of the physicians across all examination administrations was 45.02 (±5.18) years (range = 35 to 72 years). The mean (±SD) ConCert examination score across all administrations was 85.39 (±5.71; range = 51 to 100). Among first‐time ConCert examination takers, older age was associated with lower examination scores (r = –0.25, p < 0.0001). Across all examination attempts, age was negatively correlated to examination scores (r = –0.24; p < 0.0001).ConclusionsAfter physician characteristics were controlled for, there was an association between advancing age and declining performance on the ABEM ConCert examination. This information may be important to the individual physician to develop targeted competency assessment and professional development.
Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis
Manohar, Sandhya , Kompotiatis, Panagiotis , Thongprayoon, Charat , Cheungpasitporn, Wisit , Herrmann, Joerg , Herrmann, Sandra M. , Cheungpasitporn, Wisit , Thongprayoon, Charat , Herrmann, Sandra M

Mayo Clinic

Nephrology Dialysis Transplantation | April 2, 2018 | Volume: 34 | Issue: 1 | Pages: 108-117

10.1093/ndt/gfy105 | PMID 29762725 Get It

3D Virtual Broncoscopy before FETO Procedure in a Fetus with Severe, Isolated Left Congenital Diaphragmatic Hernia
Tonni, Gabriele , Sá, Renato Augusto Moreira de , Filho, Fernando Maia Peixoto , Werner, Heron , Ruano, Rodrigo , Lopes, Jorge

Mayo Clinic

Fetal and Pediatric Pathology | April 2, 2018 | Volume: 37 | Issue: 2 | Pages: 134-139

10.1080/15513815.2018.1445148 | PMID 29608113 Get It

Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation
Zhu, Qianqian , Yan, Li , Liu, Qian , Zhang, Chi , Preus, Leah, Clay‐Gilmour, Alyssa , Onel, Kenan , Pooler, Loreall , Sheng, Xin , Haiman, Christopher A. , Zhu, Xiaochun , Pasquini, Marcelo C. , Liu, Song , Hahn, Theresa , Sucheston‐Campbell, Lara E. , Clay-Gilmour, Alyssa I, Wei, Lei , Hu, Qiang , Stram, Daniel O. , Spellman, Stephen R. , McCarthy, Philip L.

Mayo Clinic

Blood | April 2, 2018 | Volume: 131 | Issue: 22 | Pages: 2490-2499

10.1182/blood-2017-11-817973 | PMID 29610366 Get It

Key Points We conducted the first exome-wide association study between germ line variant genotype and survival outcomes after unrelated-donor BMT. A number of novel genes were found to significantly affect survival outcomes.
Intra-Operative Inspired Fraction of Oxygen and the Risk of Surgical Site Infections in Patients with Type 1 Surgical Incisions
Wanta, Brendan T., Hanson, Kristine T. , Hyder, Joseph A. , Stewart, Thomas M. , Curry, Timothy B. , Berbari, Elie F. , Habermann, Elizabeth B. , Kor, Daryl J. , Brown, Michael , Habermann, Elizabeth , Hanson, Kristine

Mayo Clinic

Surgical Infections | April 2, 2018 | Volume: 19 | Issue: 4 | Pages: 403-409

10.1089/sur.2017.246 | PMID 29608437 Get It